Impact on the adult population of immunization with nirsevimab in children under 6 months of age against respiratory syncytial virus

被引：0
|
作者：
Reina, Jordi [1 ]
Viana-Ramirez, Julia [1 ]
机构：
[1] Hosp Univ Son Espases, Serv Microbiol, Unidad Virol, Carretera Valldemossa 79, Palma De Mallorca 07120, Spain
来源：
REVISTA ESPANOLA DE QUIMIOTERAPIA | 2024年 / 37卷 / 06期
关键词：
INFECTIONS;
D O I：
10.37201/req/049.2024
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：96
相关论文
共 50 条
  • [21] Impact of Respiratory Syncytial Virus and Influenza Virus Infection in the Adult Population in Spain between 2012 and 2020
    Heppe-Montero, Marco
    Gil-Prieto, Ruth
    del Diego Salas, Jorge
    Hernandez-Barrera, Valentin
    Gil-de-Miguel, Angel
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (22)
  • [22] Microorganisms associated with respiratory syncytial virus pneumonia in the adult population
    M. Jeannoël
    G. Lina
    J. P. Rasigade
    B. Lina
    F. Morfin
    Jean Sebastien Casalegno
    European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 157 - 160
  • [23] Microorganisms associated with respiratory syncytial virus pneumonia in the adult population
    Jeannoel, M.
    Lina, G.
    Rasigade, J. P.
    Lina, B.
    Morfin, F.
    Casalegno, Jean Sebastien
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (01) : 157 - 160
  • [24] Respiratory Syncytial Virus-Associated Hospitalizations Among Children Less Than 24 Months of Age
    Breese, Caroline
    Weinberg, Geoffrey A.
    Blumkin, Aaron K.
    Edwards, Kathryn M.
    Staat, Mary A.
    Schultz, Andrew F.
    Poehling, Katherine A.
    Szilagyi, Peter G.
    Griffin, Marie R.
    Williams, John V.
    Zhu, Yuwei
    Grijalva, Carlos G.
    Prill, Mila M.
    Iwane, Marika K.
    PEDIATRICS, 2013, 132 (02) : E341 - E348
  • [25] Nirsevimab: Expansion of Respiratory Syncytial Virus Prevention Options in Neonates, Infants, and At-Risk Young Children
    Fly, J. Hunter
    Eiland, Lea S.
    Stultz, Jeremy S.
    ANNALS OF PHARMACOTHERAPY, 2025, 59 (01) : 81 - 91
  • [26] ECONOMIC AND CLINICAL BURDEN ASSOCIATED WITH RESPIRATORY SYNCYTIAL VIRUS (RSV) AND EXPECTED IMPACT OF UNIVERSAL IMMUNIZATION WITH NIRSEVIMAB AMONG ALL INFANTS IN THEIR FIRST RSV SEASON AGAINST STANDARD OF CARE IN ITALY
    Bini, C.
    Marcellusi, A.
    Muzii, B.
    Soudani, S.
    Kieffer, A.
    Beuvelet, M.
    Mennini, F. S.
    VALUE IN HEALTH, 2023, 26 (12) : S188 - S188
  • [27] Respiratory syncytial virus immunoglobulin as prophylaxis against respiratory syncytial virus in children with congenital heart disease.
    Simoes, EAF
    Sondheimer, HM
    Meissner, HC
    Welliver, RC
    Groothuis, JR
    PEDIATRIC RESEARCH, 1996, 39 (04) : 662 - 662
  • [28] Accurately Assessing the Expected Impact of Universal First Respiratory Syncytial Virus (RSV) Season Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants
    Fullarton, John
    Keary, Ian
    Paes, Bosco
    Tarride, Jean-Eric
    Carbonell-Estrany, Xavier
    Rodgers-Gray, Barry
    JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (11): : 1333 - 1334
  • [29] Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
    Jones, Jefferson M.
    Fleming-Dutra, Katherine E.
    Prill, Mila M.
    Roper, Lauren E.
    Brooks, Oliver
    Sanchez, Pablo J.
    Kotton, Camille N.
    Mahon, Barbara E.
    Meyer, Sarah
    Long, Sarah S.
    Mcmorrow, Meredith L.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (34): : 920 - 925
  • [30] Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024
    Moline, Heidi L.
    Toepfer, Ariana P.
    Tannis, Ayzsa
    Weinberg, Geoffrey A.
    Staat, Mary A.
    Halasa, Natasha B.
    Boom, Julie A.
    Klein, Eileen J.
    Williams, John V.
    Schuster, Jennifer E.
    Goldstein, Leah
    Mckeever, Erin R.
    Kalman, Casey
    Paden, Clinton
    Atherton, Lydia
    Aggarwal, Megha
    Roychoudhury, Pavitra
    Piedra, Pedro A.
    Sahni, Leila C.
    Stewart, Laura S.
    Selvarangan, Rangaraj
    Michaels, Marian G.
    Schlaudecker, Elizabeth P.
    Szilagyi, Peter G.
    Englund, Janet A.
    Clopper, Benjamin R.
    Thornburg, Natalie J.
    Derado, Gordana
    Mcmorrow, Meredith L.
    Dawood, Fatimah S.
    New Vaccine Surveillance Network Collaborators
    JAMA PEDIATRICS, 2025, 179 (02) : 179 - 187
12345